Helus Pharma (R7E.F) Q1 2026 Earnings

16FebConfirmed
Q1 2025
Q3 2025
Q4 2025
Q1 2026
-1.17
-0.9
-0.63
-0.36

Details

Expected EPS
-0.6416378818377
Actual EPS
-0.837509457543
Surprise EPS
-0.2
Surprise Percent
+30.53%

Description

Helus Pharma (R7E.F) has reported earnings of -0.837509457543 per share for Q1 2026.

0 Comments

Share your thoughts